The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
By Amy Nordrum @amynordrum On 02/13/16 AT 8:37 AM. Soliris is widely considered the worldâs most expensive drug, at an average annual price of $440,000. It was first approved in 2007 and treats a rare blood disorder that affects only a few thousand patients in the U.S. and Europe. Photo: Alexion Pharmaceuticals.